Close

Eli Lilly & Co. (LLY), Adocia Announce Positive Top-Line Data from BioChaperone Lispro Phase 1

May 31, 2016 12:02 PM EDT Send to a Friend
Adocia and Eli Lilly and Company (NYSE: LLY) announced positive topline results from a Phase 1 clinical trial evaluating BioChaperone ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login